Annual Information Statement 2021

Legal Name
CRESTANI SCHOLARSHIPS LIMITED
ABN
16636693528

About the charity

Charity size
Small
Is the charity an incorporated association?
No
Does the charity intend to fundraise in the next reporting period?
Yes
Select the state/territory where the charity intends to fundraise in the 2021 reporting period
NSW fundraising number: CFN/25584
Is the charity a Basic Religious Charity?
No

Charity programs

Program name
Crestani Scholarship Award
Program classification
Medical specialties
Program locations
NSW, Australia
Program beneficiaries
  • People with chronic illness (including terminal illness)
  • General community in Australia

Description of the charities activities and outcomes
Funds raised are offered as scholarships to trained specialist in the treatment of cancer suffers to advance their knowledge and training in the latest treatments available in order to achieve the best possible outcome for cancer patients

Human Resources

Employees and volunteers
  • Full time employees: 0
  • Part time employees: 0
  • Casual employees: 0
  • Full-time equivalent staff (FTE): 0
  • Estimated number of volunteers: 15

Financial Reporting

Charity's 2021 reporting period
1 July 2020 to 30 June 2021
Accounting method used in the 2021 reporting period
Accrual

Income and Expenses

Income Statement summary

Revenue/receipts
Donations and bequests
$64,549.00
Revenue from providing goods or services
$7,617.00
Revenue from government including grants
$8,275.00
Revenue from investments
$1,219.00
Other revenue/receipts
$3,102.00
Total revenue/receipts
$84,762.00
Other income (for example, gains)
$0.00
Total income/receipts
$84,762.00
Expenses/Payments
Employee expenses/payments
$0.00
Grants and donations made for use in Australia
$8,945.00
Grants and donations made for use outside Australia
$0.00
Other expenses/payments
$17,393.00
Total expenses/payments
$26,338.00
Net surplus/(deficit)
$58,424.00

Balance Sheet Extract

Total assets
$301,592.00
Total liabilities
$0.00
Net assets/liabilites
$301,592.00